From Medicine to Monster: Ep 4 – From Monster to Modern Medicine

From Medicine to Monster: Episode 4 – From Monster to Modern Medicine

California Realizes Marijuana is Medicine

After decades of fear, propaganda, and federal crackdowns, the “monster” of marijuana started to show cracks in the 1990s. Science, advocacy, and brave patients began peeling away the layers of lies that had demonized a plant for generations.

California, 1996: The first state to legalize medical marijuana with Proposition 215. Patients suffering from AIDS, cancer, and chronic pain finally had legal access to relief. Suddenly, the Schedule I “monster” had a human face—people whose lives depended on cannabis.

States followed one by one. Colorado and Washington led the charge in recreational legalization in 2012. The public began to see cannabis not as a threat, but as medicine, wellness, and even economic opportunity.

Meanwhile, research surged. Studies highlighted marijuana’s therapeutic potential for pain, epilepsy, PTSD, and more. Even mainstream media slowly shifted tone: no longer just “reefer madness,” but stories of patients, entrepreneurs, and science reclaiming the narrative.

Yet federally, cannabis remained trapped in Schedule I hell. Banks refused to work with cannabis businesses, interstate commerce was illegal, and millions still faced criminal records. The “monster” wasn’t gone—it was slowly being tamed by states, advocates, and markets.

Today, the story continues globally. Canada, Mexico, much of Europe, and parts of Asia are opening legal doors. Tennessee Cannabiz readers need to know: what was once a political monster is now a medical miracle, cultural movement, and economic powerhouse.

Stay tuned for Episode 5: The Monster Today, where we’ll explore federal battles, rescheduling, global trends, and why cannabis remains a force the world can’t ignore.

🌿 Explore the Series 🌿

⬅ Previous | Series Hub | Next ➡

Comments

People's Choice

A Thank You Letter To President Trump for Opening the Door to Cannabis Research

Trump's Cannabis From Schedule I to Schedule III Move Dear President Trump, I want to extend a sincere and enthusiastic thank you for your leadership in considering and moving forward with the rescheduling of marijuana from a Schedule I to a Schedule III controlled substance — a step that has already begun to reshape the national conversation around cannabis, research, and medical science. Your public remarks acknowledging that many people want this reclassification because it “leads to tremendous amounts of research that can’t be done unless you reclassify” reflect a willingness to look beyond old stigmas and recognize the potential for science and medicine to understand cannabis more fully. This shift — which would acknowledge cannabis as a substance with accepted medical use and a lower potential for abuse relative to Schedule I drugs — marks one of the most significant federal policy considerations in decades. By opening the door to research, innovation, an...

Key differences Between Schedule I and Schedule III — What Rescheduling Marijuana Could Mean

Key differences Between Schedule I and Schedule III — What Rescheduling Marijuana Could Mean Schedule I vs Schedule III Under the U.S. Controlled Substances Act (CSA), drugs are classified into schedules based on their accepted medical use, potential for abuse, and risk of dependence. Two key schedules in this context are Schedule I and Schedule III: Schedule I : Drugs with no currently accepted medical use in the U.S., a high potential for abuse , and potentially severe psychological or physical dependence. Examples include heroin, LSD, and currently, marijuana (cannabis). Schedule III : Drugs with accepted medical use , moderate to low potential for physical and psychological dependence, and a lower abuse risk compared to Schedules I or II. Examples include ketamine, anabolic steroids, testosterone, and certain codeine combinations (like Tylenol with codeine). Rescheduling marijuana from Schedule I to Schedule III would formally recognize its medical benefits...

What Is Nerolidol?

Because of its sedative qualities, nerolidol-rich strains are often favored for evening use or for relaxation. What Is Nerolidol? Nerolidol is a naturally occurring sesquiterpene found in many plants. It has a distinctive aroma described as woody, floral, and slightly citrusy, often reminiscent of fresh ginger, jasmine, or bark. This terpene is known for its calming, sedative qualities and is commonly used in perfumes, cosmetics, and traditional herbal medicines. Nerolidol in Cannabis In cannabis, nerolidol contributes a subtle, complex aroma that blends woodsy and floral notes. It’s less common than some other terpenes but plays an important role in the overall scent and effect profile of certain strains. Strains high in nerolidol tend to be: Woody and floral Earthy with a touch of citrus Smooth and mellow Nerolidol itself does not produce intoxication but interacts with cannabinoids like THC and CBD to shape the overall experience. Effects Commo...

The Cannabis Beverage Revolution: How THC Drinks Are Disrupting Big Alcohol (And Why Tennessee Shut Them Down)

THC-infused beverages are rapidly replacing alcohol for many consumers—triggering a coordinated backlash from the alcohol industry that culminated in Tennessee’s 2025 hemp crackdown. The Cannabis Beverage Revolution: How THC Drinks Are Disrupting Big Alcohol (And Why Tennessee Shut Them Down) A Deep Dive Into the Fastest-Growing Segment of the Cannabis Industry—And the Billion-Dollar Threat That Triggered Tennessee's Crackdown Jump to: Market Explosion Alcohol Industry Threat Big Alcohol's Response Tennessee's Response Product Reality Health Comparison Market Reality Federal Complication Tennessee's Position The Future Conclusion When Tennessee transferred hemp regulation to the Tennessee Alcoholic Beverage Commission on January 1, 2026, most people assumed it was about public safety or protecting children. But the real story is far more revealing: it's about protecting the alcohol ind...

Free the Green: A Letter to President Donald J. Trump

🇺🇸 Free the Green: A Letter to President Donald J. Trump An Open Plea from the American People & the Cannabis Family Legalize It President Trump, It’s time to Free the Green — to remove marijuana from the federal Schedule I classification, where it has been trapped since the Nixon era. A Law Without a Vote Few Americans realize that marijuana’s placement as a Schedule I drug — supposedly with “no medical value and a high potential for abuse” — was never voted on by Congress . It was assigned there in 1970 under the Controlled Substances Act by executive direction, intended as a temporary classification until a scientific commission could study the plant and make recommendations. That commission, known as the Shafer Commission , did complete its work — and in 1972, it recommended that marijuana should not be criminalized and should be removed from Schedule I entirely. The findings were ignored. Politics won. Science lost. And for over fifty years, that mi...

Tennessee Cannabiz

Search This Blog